Literature DB >> 33418866

Comparison of Five Oral Cannabidiol Preparations in Adult Humans: Pharmacokinetics, Body Composition, and Heart Rate Variability.

Natasha N Bondareva Williams1, Taylor Russell Ewell1, Kieran Shay Struebin Abbotts1, Kole Jerel Harms1, Keith A Woelfel2, Gregory P Dooley3, Tiffany L Weir4, Christopher Bell1.   

Abstract

Data supporting the physiological effects of cannabidiol (CBD) ingestion in humans are conflicting. Differences between CBD preparations and bioavailability may contribute to these discrepancies. Further, an influence of body composition on CBD bioavailability is feasible, but currently undocumented. The aims of this study were to: (1) compare the pharmacokinetics of five oral CBD preparations over 4 h; (2) examine the relationship between body composition and CBD pharmacokinetics; and, (3) explore the influence of CBD on heart rate variability. In total, five preparations of CBD, standardized to 30 mg, were orally administered to 15 healthy men and women (21-62 years) in a randomized, crossover design. Prior to and 60 min following CBD ingestion, heart rate variability was determined. Body composition was assessed using dual energy X-ray absorptiometry. Peak circulating CBD concentration, time to peak concentration, and area under the curve was superior in a preparation comprising 5% CBD concentration liquid. Fat free mass was a significant predictor (R 2 = 0.365, p = 0.017) of time to peak concentration for this preparation. Several heart rate variability parameters, including peak frequency of the high frequency band, were favorably, but modestly modified following CBD ingestion. These data confirm an influence of CBD preparation and body composition on CBD bioavailability, and suggest that acute CBD ingestion may have a modest influence on autonomic regulation of heart rate.

Entities:  

Keywords:  autonomic; bioavailability; fat free mass

Year:  2021        PMID: 33418866      PMCID: PMC7825058          DOI: 10.3390/ph14010035

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  44 in total

Review 1.  Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Authors:  Orrin Devinsky; Maria Roberta Cilio; Helen Cross; Javier Fernandez-Ruiz; Jacqueline French; Charlotte Hill; Russell Katz; Vincenzo Di Marzo; Didier Jutras-Aswad; William George Notcutt; Jose Martinez-Orgado; Philip J Robson; Brian G Rohrback; Elizabeth Thiele; Benjamin Whalley; Daniel Friedman
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

2.  Exercise increases plasma THC concentrations in regular cannabis users.

Authors:  Alexander Wong; Mark E Montebello; Melissa M Norberg; Kieron Rooney; Nicholas Lintzeris; Raimondo Bruno; Jessica Booth; Jonathon C Arnold; Iain S McGregor
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

3.  A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers.

Authors:  Adele Hosseini; Andrew J McLachlan; Jason D Lickliter
Journal:  Br J Clin Pharmacol       Date:  2020-11-18       Impact factor: 4.335

4.  Effects of Hemp Extract on Markers of Wellness, Stress Resilience, Recovery and Clinical Biomarkers of Safety in Overweight, But Otherwise Healthy Subjects.

Authors:  Hector L Lopez; Kyle R Cesareo; Betsy Raub; A William Kedia; Jennifer E Sandrock; Chad M Kerksick; Tim N Ziegenfuss
Journal:  J Diet Suppl       Date:  2020-05-27

5.  Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.

Authors:  Kerri A Schoedel; Isabella Szeto; Beatrice Setnik; Edward M Sellers; Naama Levy-Cooperman; Catherine Mills; Tilden Etges; Kenneth Sommerville
Journal:  Epilepsy Behav       Date:  2018-10-02       Impact factor: 2.937

6.  Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.

Authors:  Irina Cherniakov; Dvora Izgelov; Dinorah Barasch; Elyad Davidson; Abraham J Domb; Amnon Hoffman
Journal:  J Control Release       Date:  2017-09-08       Impact factor: 9.776

7.  Total blood volume in healthy young and older men.

Authors:  K P Davy; D R Seals
Journal:  J Appl Physiol (1985)       Date:  1994-05

8.  A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain.

Authors:  Chris D Verrico; Shonda Wesson; Vanaja Konduri; Colby J Hofferek; Jonathan Vazquez-Perez; Emek Blair; Kenneth Dunner; Pedram Salimpour; William K Decker; Matthew M Halpert
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

9.  A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.

Authors:  Lesley Taylor; Barry Gidal; Graham Blakey; Bola Tayo; Gilmour Morrison
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

View more
  4 in total

Review 1.  Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.

Authors:  Barbara Stella; Francesca Baratta; Carlo Della Pepa; Silvia Arpicco; Daniela Gastaldi; Franco Dosio
Journal:  Drugs       Date:  2021-09-04       Impact factor: 9.546

2.  Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue.

Authors:  Robert B Child; Mark J Tallon
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

3.  Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function.

Authors:  Kieran Shay Struebin Abbotts; Taylor Russell Ewell; Hannah Michelle Butterklee; Matthew Charles Bomar; Natalie Akagi; Gregory P Dooley; Christopher Bell
Journal:  Nutrients       Date:  2022-05-21       Impact factor: 6.706

4.  Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey.

Authors:  Susan Mohamed; Giovanna Lopane; Loredana Sabattini; Cinzia Scandellari; Diletta Zardi; Vincenzo Donadio; Giovanni Rizzo; Alessandro Perrone; Alessandra Lugaresi; Manuela Contin
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.